Clovis Oncology
CLVS
#9721
Rank
โ‚ฌ10.81 M
Marketcap
0,07462ย โ‚ฌ
Share price
0.00%
Change (1 day)
-95.14%
Change (1 year)

Operating Margin for Clovis Oncology (CLVS)

Operating Margin as of November 2024 (TTM): -163.43%

According to Clovis Oncology's latest financial reports and stock price the company's current Operating Margin is -163.43%. At the end of 2021 the company had an Operating Margin of -178.09%.

Operating Margin history for Clovis Oncology from 2017 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-178.09%-20.76%
2020-224.75%-19.37%
2019-278.75%-27.63%
2018-385.16%-38.91%
2017-630.46%-99.87%
2016-488,680.77%
2014-1,157.60%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
14.22%-108.70%๐Ÿ‡บ๐Ÿ‡ธ USA
15.05%-109.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
1.80%-101.10%๐Ÿ‡บ๐Ÿ‡ธ USA
17.68%-110.82%๐Ÿ‡บ๐Ÿ‡ธ USA
12.84%-107.86%๐Ÿ‡บ๐Ÿ‡ธ USA
24.84%-115.20%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.